近日，国际四大顶级医学期刊之一《BMJ》，以“Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE ...

Dual antiplatelet therapy with aspirin and clopidogrel is effective in limiting adverse coronary thromboischemic events in most patients undergoing coronary stenting. However, platelet reactivity ...

While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially ...

Dual antiplatelet therapy for 1 month was inferior to 3 months for patients with high bleeding risk after PCI. DAPT for 3 months was superior to 12 months for patients with low bleeding risk.

2012;6(2):211-221. It is also useful to consider for how long it is relatively safe to cease dual antiplatelet therapy. An analysis of 161 cases of late or very late in-stent thrombosis (i.e., >30 ...

Get Instant Summarized Text (Gist) A novel nanoparticle therapy has been developed to combat obesity by converting white fat into calorie-burning beige fat and reducing inflammation. This approach ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with ...

LTD's Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA ...